FifeR.PatonJ. P. J.WhyteW. G. (1958). Treatment of hypertension in out patients: The initial assessment and the effect of reserpine. Scot. med. J., 3, 165.
2.
MaxwellR. D. G.CampbellA. J. M. (1953). New sympathicolytjc agents. Lancet, 1, 455.
3.
MayerJ. H.MillerS. I.FordR. V. (1953). Orally administered hexamethonium chloride in hypertension. J. Amer. med. Ass., 152, 1121.
4.
SmirkF. H. (1953). Action of a new methonium compound in arterial hypertension: Pentamethylene 1: 5-(bis)-N-(N-methyl-pyrrolidinium) bitartrate (M. and B. 2050). Lancet, 1, 457.
5.
SmirkF. H. (1957). High Arterial Pressure.Oxford: Blackwell Scientific Publications, Ltd.
6.
SmithK. S.FowlerP. B. S.EdmundsV. (1954). Hypertension and its control by hexamethonium. Brit. med. J., 2, 1243.
7.
WylieW. D.Churchill-DavidsonH. C. (1951). A side-action of hexamethonium compounds. Brit. med. J., 2, 54.